A world-leading medical solutions company

We design and supply medical solutions to enhance performance in healthcare – from the hospital to the home.
Around the world, healthcare systems and professionals are under pressure to deliver better care, to more people, for better value. They need innovative solutions they can trust. That’s where we come in. We’re here to advance performance in healthcare. So we’re always on the lookout for new ways to improve. Our focus: providing effective solutions and offering better value for money.

About Mölnlycke Health Care

Wound care products
Discover the Mepilex® range of wound treatment and prevention solutions – delivering clinically-proven better outcomes with less pain for patients.
Wound management
Oxygen Therapy and Wound Irrigation
purified haemoglobin is released. This binds with oxygen from the environment and diffuses through the wound exudate, and the haemoglobin supplies the base of the wound topically with oxygen. The oxygen supply to the base of the wound supports wound healing and patient outcomes
Mepilex dressings
Discover the Mepilex® range of wound treatment and prevention solutions – delivering clinically-proven better outcomes with less pain for patients.
If you wish to Purchase one of product  check our Wound care Products
The pressures placed on quality care are mounting from all sides
Pressure injuries are a growing problem that affects practically every aspect of a health system.
Hospital-acquired pressure ulcers and injuries are causing significant patient harm and treatment is becoming increasingly expensive
. Budgets for wound care materials are being cut, making HAPU/I management even more difficult.
The pressure to swap quality products for low cost may pose a threat to the delivery of patient care.

more than > 2.5 M

Patients in U.S. acutecare facilities suffer from Pressure Ulcer

$ 26.8 B worth of

Annual treatment cost of Pressure Ulcers in the U.S. $ 70,000 for one facility

more than 60,000

Die from complications each year 1 

Our products and solutions include
Every day, patients around the world suffer physically and emotionally from acute and chronic wounds.
These wounds can be persistent, difficult to treat and costly to manage. Mölnlycke works with patients, c
aregivers and healthcare systems to reduce the burden of these wounds
through innovative solutions for prevention, faster healing and better quality of life.
Multi-layered bordered dressings designed to conform and stay on complex wounds such as pressure ulcers, leg and foot ulcers and traumatic wounds. 

 

Dressings used to treat medium to highly exuding wounds including cavities. The dressings transform into a gel upon contact with exudate, helping them to softly conform to the wound bed. Read more about Exufiber® and Exufiber® Ag+
Solutions include Granulox®, a haemoglobin oxygenating spray used in the treatment of chronic wounds, and Granudacyn®, an irrigation solution for cleansing and moisturising acute, chronic and contaminated wounds, as well as for first and second degree burns.
A portable battery-powered single use negative pressure wound care system used to draw out exudate and infectious material from chronic and surgical incisions. 
Absorbent foam dressings for chronic and acute wounds with Safetac® soft silicone adhesion, helping to reduce pain and minimise damage to the wound and skin at removal. Read more about Mepilex®and Mepilex® Ag.
In managing wounds it remains a common practice to either use soap and water or stronger solutions. The problem is that soap and water are ineffective against some pathogens whereas many stronger solutions potentially disturb the healing process, and potentially damage human cells.
Granudacyn® is your go-to wound cleanser – cleaning wounds, supporting healing.

OUR KNOLWDGE

Explore our knowledge and expertise – we’re passionate about sharing what we have learned with healthcare professionals to advance standards of care.
Diabetic foot ulcers are a common and serious complication of both type 1 and type 2 diabetes mellitus. Diabetes is associated with ischaemia, neuropathy and deformities that lead to a particularly high risk of developing foot ulcers and a low likelihood of ulcer healing.
Read More
Safetac®’s journey all began with a man named Tomas Fabo. In the mid-1980s, he was a young product developer working in the research and development department of Mölnlycke®’s wound care division..
Read More